| Literature DB >> 32610482 |
Feng Li1,2,3,4, Minggang Cai1,2,3,4, Mingwei Lin4, Xianghu Huang1, Jun Wang4,5, Hongwei Ke3,4, Chunhui Wang3,4, Xuehong Zheng3,4, Ding Chen3,4, Shihui Yang4.
Abstract
: Astaxanthin from H. pluvialis is an antioxidant and presents a promising application in medicine for human health. The two-stage strategy has been widely adopted to produce astaxanthin by the Haematococcus industry and research community. However, cell death and low astaxanthin productivity have seriously affected the stability of astaxanthin production. This study aims to test the effect of cell transformation strategies on the production of astaxanthin from H. pluvialis and determine the optimal initial biomass density (IBD) in the red stage. The experimental design is divided into two parts, one is the vegetative growth experiment and the other is the stress experiment. The results indicated that: (1) the cell transformation strategy of H. pluvialis can effectively reduce cell death occurred in the red stage and significantly increase the biomass and astaxanthin production. (2) Compared with the control group, the cell mortality rate of the red stage in the treatment group was reduced by up to 81.6%, and the biomass and astaxanthin production was increased by 1.63 times and 2.1 times, respectively. (3) The optimal IBD was determined to be 0.5, and the highest astaxanthin content can reach 38.02 ± 2.40 mg·g-1. Thus, this work sought to give useful information that will lead to an improved understanding of the cost-effective method of cultivation of H. pluvialis for natural astaxanthin. This will be profitable for algal and medicine industry players.Entities:
Keywords: Haematococcus pluvialis; astaxanthin; cell transformation; encystment; initial biomass density
Mesh:
Substances:
Year: 2020 PMID: 32610482 PMCID: PMC7401282 DOI: 10.3390/md18070341
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1The experimental design of the vegetative growth stage (a). The biomass (b), cell number (c), and cell morphological changes (d) of two groups in the vegetative growth stage (Dark green triangle: the data in the control group. Green square: the data of vegetative growth stage in the treatment group. Orange square: the data of encystment stage in the treatment group).
Figure 2The experimental design of the red stage (a). The biomass (b) and astaxanthin concentration (c) of the control group (Gray) and treatment group (Red) under three IBDs in the red stage. The cell morphological changes (d) of two groups under 0.5 IBD.
The maximum value of biomass, biomass productivity, astaxanthin concentration, astaxanthin productivity, astaxanthin content, and astaxanthin content increase rate of the control- and treatment group under different IBDs.
| Parameters | IBD: 0.2 | IBD: 0.5 | IBD: 0.8 | |||
|---|---|---|---|---|---|---|
| Control Group | Treatment Group | Control Group | Treatment Group | Control Group | Treatment Group | |
| Biomass (g L−1) | 0.58 ± 0.06 | 0.92 ± 0.06 | 1.24 ± 0.13 | 2.02 ± 0.03 | 1.66 ± 0.08 | 2.62 ± 0.06 |
| Biomass productivity | 0.34 ± 0.04 | 0.44 ± 0.49 | 0.50 ± 0.08 | 0.66 ± 0.04 | 0.62 ± 0.04 | 0.72 ± 0.05 |
| Astaxanthin concentration | 15.62 ± 1.35 | 32.26 ± 2.76 | 34.67 ± 2.91 | 72.51 ± 0.82 | 43.63 ± 3.03 | 87.35 ± 0.40 |
| Astaxanthin productivity | 2.76 ± 0.33 | 5.42 ± 0.59 | 5.42 ± 0.05 | 11.36 ± 0.83 | 6.68 ± 0.66 | 12.37 ± 0.02 |
| Astaxanthin content (mg g−1) | 27.29 ± 0.67 | 35.29 ± 2.66 | 29.99 ± 1.43 | 38.02 ± 2.40 | 26.19 ± 0.59 | 33.35 ± 0.87 |
| Astaxanthin content increase rate | 0.34 ± 0.01 | 0.54 ± 0.03 | 0.41 ± 0.10 | 0.74 ± 0.07 | 0.46 ± 0.06 | 0.65 ± 0.00 |
| Cell mortality rate ( | 25.85 ± 1.20 | 7.63 ± 3.35 | 23.14 ± 5.22 | 4.56 ± 0.27 | 19.08 ± 0.88 | 3.51 ± 2.48 |
The maximum value of each parameter was presented in the table. The cell mortality rate was obtained on day 8 of the red stage.
Figure 3The astaxanthin content (a) and astaxanthin content increase rate (b) of control group (Gray) and treatment group (Red) under different IBDs in the red stage.